Biogen's total assets for Q2 2025 were $28.33B, an increase of 1.06% from the previous quarter. BIIB total liabilities were $10.70B for the fiscal quarter, a -3.24% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.